Rabie,Asma Mohamed SeragEDien.

Clinical and Radiographic Evaluation of Crestal Bone Loss around Implant with or without Platform Switching Design :
Randomized Clinical Trial, Split Mouth Design / التقيم السريرى والشعاعى من فقدان العظام حول قمة العظم مع اوبدون تصميم منصة التبديل (التجارب السريرية العشوائية وتصميم الفم الانقسام
Asma Mohamed SeragEDien Rabie; Supervised by Mona Ali Shoeib,Shahira Aldomiaty,Enji Ahmed Mahmoud. - Cairo : Cairo University. Faculty Of Oral and Dental Medicine. Department Of oral Medicine. 2017. - 146(3)leaves ; ill. ; 27 cm + 1 CD.

Thesis (Ph.D.) - Cairo University. Faculty Of Oral and Dental Medicine. Department Of oral Medicine.


Includes bibliographical references.


Objective: This randomized clinical trial aimed to compare between platform switched implants and platform matched implants regarding change in marginal bone level up to 9 month after final prosthetic reconstruction using Cone beam computed tomography (CBCT) and periotest.
Material and methods: The study included a total of 26 implants in 12 patients, inserted and positioned at the crestal bone level, and randomly assigned into two groups either platform-matched (control) or a platform-switched (mismatch 0.35-0.6 mm) implant abutment connection (test). Outcome measures were patient’s satisfaction, implant mobility, and radiographic crestal bone-level changes. These parameters were assessed preoperatively, 3 months after implant placement and 9 months after placing the implant crown.
Results: For all the measured outcomes, there was no statistically significant difference between the two groups. However after 9 months, platform-switched group showed statistically significantly lower mean percentage of crestal bone loss than platform-matched group.
Conclusions: within the limitation of the current study, the results suggested that there was no difference between both groups and platform diameter does not have a true impact upon hard tissue response around dental implants



Text in English, abstracts in English & Arabic.



Implant

617.63 / R C